Partnerships are pivotal

Traditionally Life Sciences companies have successfully managed the entire product life cycle from research and development (R&D) to commercialization entirely on their own. For many companies, this model no longer works for reasons beyond the obvious economics. The new way forward is collaboration with other companies to develop effective new drugs. These collaborations have proven to:

Given the parameters of R&D today, collaborations and partnerships are pivotal in driving product innovation. Many of these collaborations are entered into with the goal of achieving certain positive patient clinical outcomes for new specialty therapeutics. This may require the expertise of one partner’s treatment in a particular disease combined with the other partner’s experience in areas such as digital therapeutics. Together these companies can develop and commercialize a therapeutic with shared risk, increased productivity and ultimately, reduced time to market.